1. Home
  2. FHTX vs PWOD Comparison

FHTX vs PWOD Comparison

Compare FHTX & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHTX
  • PWOD
  • Stock Information
  • Founded
  • FHTX 2015
  • PWOD 1934
  • Country
  • FHTX United States
  • PWOD United States
  • Employees
  • FHTX N/A
  • PWOD N/A
  • Industry
  • FHTX Medicinal Chemicals and Botanical Products
  • PWOD Major Banks
  • Sector
  • FHTX Health Care
  • PWOD Finance
  • Exchange
  • FHTX Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • FHTX 237.4M
  • PWOD 227.1M
  • IPO Year
  • FHTX 2020
  • PWOD N/A
  • Fundamental
  • Price
  • FHTX $4.32
  • PWOD $30.72
  • Analyst Decision
  • FHTX Strong Buy
  • PWOD
  • Analyst Count
  • FHTX 5
  • PWOD 0
  • Target Price
  • FHTX $13.80
  • PWOD N/A
  • AVG Volume (30 Days)
  • FHTX 170.9K
  • PWOD 24.6K
  • Earning Date
  • FHTX 03-06-2025
  • PWOD 01-31-2025
  • Dividend Yield
  • FHTX N/A
  • PWOD 4.14%
  • EPS Growth
  • FHTX N/A
  • PWOD 20.90
  • EPS
  • FHTX N/A
  • PWOD 2.62
  • Revenue
  • FHTX $25,515,000.00
  • PWOD $67,724,000.00
  • Revenue This Year
  • FHTX N/A
  • PWOD N/A
  • Revenue Next Year
  • FHTX $7.37
  • PWOD N/A
  • P/E Ratio
  • FHTX N/A
  • PWOD $11.70
  • Revenue Growth
  • FHTX N/A
  • PWOD 5.88
  • 52 Week Low
  • FHTX $2.70
  • PWOD $17.01
  • 52 Week High
  • FHTX $10.25
  • PWOD $34.56
  • Technical
  • Relative Strength Index (RSI)
  • FHTX 33.35
  • PWOD 51.75
  • Support Level
  • FHTX $4.13
  • PWOD $28.69
  • Resistance Level
  • FHTX $4.52
  • PWOD $30.97
  • Average True Range (ATR)
  • FHTX 0.34
  • PWOD 0.67
  • MACD
  • FHTX 0.08
  • PWOD 0.05
  • Stochastic Oscillator
  • FHTX 20.88
  • PWOD 88.26

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: